Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA).

And retail traders should know.

We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TEVA, it often means somebody knows something is about to happen.

So how do we know what these investors just did?

Today, Benzinga's options scanner spotted 8 uncommon options trades for Teva Pharmaceutical Indus.

This isn't normal.

The overall sentiment of these big-money traders is split between 12% bullish and 50%, bearish.

Out of all of the special options we uncovered, 6 are puts, for a total amount of $288,604, and 2 are calls, for a total amount of $143,091.

Projected Price Targets

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $15.0 to $17.0 for Teva Pharmaceutical Indus during the past quarter.

Insights into Volume & Open Interest

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Teva Pharmaceutical Indus's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Teva Pharmaceutical Indus's whale trades within a strike price range from $15.0 to $17.0 in the last 30 days.

Teva Pharmaceutical Indus 30-Day Option Volume & Interest Snapshot

Biggest Options Spotted:

About Teva Pharmaceutical Indus

In light of the recent options history for Teva Pharmaceutical Indus, it's now appropriate to focus on the company itself. We aim to explore its current performance.

Where Is Teva Pharmaceutical Indus Standing Right Now?

• With a volume of 4,482,422, the price of TEVA is down -0.68% at $16.71.
• RSI indicators hint that the underlying stock may be oversold.
• Next earnings are expected to be released in 86 days.

Expert Opinions on Teva Pharmaceutical Indus

In the last month, 4 experts released ratings on this stock with an average target price of $28.25.

Unusual Options Activity Detected: Smart Money on the Move

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Teva Pharmaceutical Indus options trades with real-time alerts from Benzinga Pro.